Sangamo BioSciences | SGMO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Alaunos Therapeutics USD 46M 39M 2026-06
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Alterity Therapeutics Limited AUD 36M 20M 2026-06
Amgen USD 189.89B 13.64B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cipla INR 988.89B 231.9B 2026-03
Clal Biotechnology ILS 43.45M 8.92M 2026-03
CSL USD 55.89B 20.42B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03